Enumeral Biomedical: Enumeral Biomedical Holdings, Inc. (ENUM: OTCQB) | Enumeral Reports First Quarter Financial Results

May 22, 2017 OTC Disclosure & News Service - Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM) ("Enumeral" or the "Company"), a biotechnology company focused on the discovery and advancement of next generation therapeutics in cancer and other diseases, today announced its financial results for the three months ended March 31, 2017. Recent Business Highlights In May [...]